Latin America Continuous Glucose Monitoring Device - Market Insights
Continuous glucose monitoring devices have the potential to improve clinical outcomes for avoiding hypo/hyperglycemic events, an outcome of uncontrolled diabetes, which can arise due to skipped insulin dose. The currently available CGM devices display the glucose level and the magnitude and direction of changing glucose levels, thus becoming a vital tool to predict the forthcoming events of hypo- and hyperglycemia. Moreover, the device is more convenient for type 1 diabetic patients, as it requires continuous monitoring of glucose for administration of insulin on regular basis. Thus, use and benefits of CGM device in controlling both type 1 diabetes and hypoglycemia & hyperglycemia is expected to drive the market growth.
The Latin America continuous glucose monitoring device market was valued at US$ 126.2 million in 2018 and is expected to witness a CAGR of 15.9% during the forecast period (2018– 2026).
Figure 1. Latin America Continuous Glucose Monitoring Device Market Share (%), By Component
Source: Coherent Market Insights Analysis (2019)
Increasing initiative by key players for distribution of continuous monitoring device in Latin America is expected to boost growth of Latin America continuous glucose monitoring device market
Major players are adopting inorganic growth strategies such as collaboration, in order to distribute their products in Latin America and increase their market share in the region. For instance, in February 2019, Senseonics Holdings, Inc. announced expansion of distribution agreement with Roche Diabetes Care by providing them with exclusive distribution rights, for distribution of implantable continuous glucose monitoring (CGM) system, in 17 countries including Brazil, Russia, India, and China as well as selected markets in the Asia Pacific and Latin American regions.
Moreover, increasing product launches by key players also contribute to growth of Latin America continuous glucose monitoring device market. Insulin pumps segment is expected to witness significant growth over the forecast period, owing to increasing product launches of insulin pumps for continuous glucose monitoring. For instance, in March 2019, Medtronic Plc. launched MiniMed 670G system, a self-adjusting insulin pump system for patients who have type 1 diabetes, in the U.K. Medtronic Plc. also supplies diabetic care products in Latin American countries such as Brazil, Chile, Colombia, and others.
However, high cost of continuous glucose monitoring devices is expected to hinder the Latin America continuous glucose monitoring device market growth. A CGM system is more expensive than using a standard glucose meter due to the sensors integrated in this system. These sensors have very short life span such as 7- 14 days and it requires continuous replacement. Thus, it may lead to high cost of the device throughout the treatment due to repetitive replacement, which may lower the user acceptance towards this device.
Latin America Continuous Glucose Monitoring Device Market – Country-wise Analysis
On the basis of country-wise segmentation, Latin America continuous glucose monitoring device market is segmented into Mexico, Argentina, Uruguay, Brazil, Colombia, Chile, Peru and Rest of Latin America.
Brazil is expected to grow at a faster pace and account for the largest market share in Latin America continuous glucose monitoring device market over the forecast period, owing to product launches in the countries. For instance, in February 2019, Abbott launched their continuous glucose monitoring system, FreeStyle LibreLink.
Mexico continuous glucose monitoring device market is expected to witness significant growth over the forecast period, owing to launch of continuous glucose monitoring devices in Mexico. For instance, in October 2017, Abbott introduced its FreeStyle Libre system in Mexico. Moreover, according to Mexican Federation of Diabetes AC, in 2017, around 9.4% of the population in Mexico was diagnosed with diabetes.
Moreover, increasing healthcare expenditure in Latin American countries such as Argentina, Colombia, Chile, and Peru is expected to boost the market growth. According to the World Health Organization (WHO), Colombia has the best and high quality healthcare system among all the Latin American countries. Moreover, increasing healthcare expenditure in Argentina is expected to aid in significant market growth. For instance, according to the World Bank, in 2014, the total health expenditure in Argentina was reported as 76.57% of the total GDP (US$ 526.32 Billion).
Figure 2: Latin America Continuous Glucose Monitoring Device Market Share (%), By Region
Source: Coherent Market Insights Analysis (2019)
Latin America Continuous Glucose Monitoring Device Market- Competitive Landscape
Key players operating in Latin America continuous glucose monitoring device market include Medtronic Plc, Abbott, F. Hoffmann-La Roche AG, Johnson & Johnson, Senseonics, Inc, Dexcom, Inc., Insulet Corporation, and Tandem Diabetes Care, Inc.
Continuous glucose monitoring devices are considered as significant systems for improving diabetes management by providing better and pain-free blood glucose measurement. Continuous glucose monitoring devices marked a remarkable change in diabetes care, as these devices provide real-time information on blood glucose levels, non-invasively than conventional glucose monitoring devices. Continuous glucose monitoring devices constantly tracks the blood glucose level throughout the day. This device consists of various components such as sensors, transmitters, and receivers for measuring and analyzing the glucose levels.
Latin America continuous glucose monitoring device market is expected to witness significant growth over the forecast period, owing to increasing incidence of diabetes in Latin American countries which may result in increasing demand for continuous glucose monitoring device in this region. For instance, according to Global Burden of Disease Study 2016, the incidence rate of diabetes in Latin America increased from 2.74% in 2010 to 3.06% in 2016. Among all countries in Latin America, diabetes affects large number of adult population based in Mexico and Brazil.
Furthermore, convenience offered by continuous glucose monitoring devices such as display of glucose trend graph and direction arrows that allow diabetic patients to anticipate approaching glucose highs and lows regularly throughout the day, may increase the demand for these devices, which in turn is expected to drive the market growth. Moreover, technological advancements in continuous glucose monitoring components such as use of sensor with long life expectancy in continuous monitoring devices that eliminates the repetitive replacement of sensors is expected to generate remarkable revenue in the market over the forecast period.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 33 market data tables and 23 figures on “Latin America Continuous Glucose Monitoring Device Market” – Country Specific forecast to 2026”.
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.